Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Reiterates Overweight Rating on Tenable (TENB)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA)
-
ASP Isotopes prices $60 million stock offering at $8 per share
-
ASP Isotopes Inc. Announces Pricing of $60 Million Underwritten Registered Direct Offering of Common Stock
-
Cantor Fitzgerald on Tesla (TSLA) Earnings
-
Space startup iRocket to go public via $400 million SPAC deal
-
TripAdvisor (TRIP) PT Raised to $17 at Cantor Fitzgerald
-
Expedia (EXPE) PT Raised to $200 at Cantor Fitzgerald
-
Booking Holdings (BKNG) PT Raised to $5,770 at Cantor Fitzgerald
-
Airbnb Inc. (ABNB) PT Raised to $130 at Cantor Fitzgerald
-
NXP Semiconductors NV (NXPI) PT Raised to $280 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Datadog (DDOG)
-
Cantor Fitzgerald Reiterates Overweight Rating on Neurocrine Bio. (NBIX)
-
Tenet Healthcare (THC) PT Raised to $190 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Neutral Rating on Texas Instruments (TXN)
-
Form 8-K Cantor Fitzgerald Income For: Jul 16
-
Pharvaris prices $175 million public offering at $20 per share
-
Pharvaris Announces Pricing of Upsized $175 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
-
Pharvaris Announces Proposed Public Offering of Ordinary Shares
-
Cantor Fitzgerald Downgrades Replimune Group (REPL) to Neutral, Only Firm Thus Far Not Buy/Overweight Rated
-
Cantor Fitzgerald Reiterates Overweight Rating on NXP Semiconductors NV (NXPI)
-
Cantor Fitzgerald Reiterates Overweight Rating on Axsome Therapeutics (AXSM)
-
Cantor Fitzgerald Reiterates Overweight Rating on Agilysys Inc (AGYS)
-
Cantor Fitzgerald Reiterates Overweight Rating on Varonis Systems (VRNS)
-
Cantor Fitzgerald Reiterates Overweight Rating on CyberArk Software (CYBR)
-
Cantor Fitzgerald Reiterates Overweight Rating on ServiceNow (NOW)
-
Cantor Fitzgerald Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)
-
Cantor Fitzgerald Reiterates Overweight Rating on Solid Biosciences (SLDB)
-
Coinbase Global Inc. (COIN) PT Raised to $500 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on JFrog (FROG)
-
Cantor Fitzgerald Reiterates Overweight Rating on CyberArk Software (CYBR)
-
Cantor Fitzgerald Reiterates Neutral Rating on Checkpoint Software (CHKP)
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA)
-
Coinbase Global Inc. (COIN) PT Raised to $500 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Tesla (TSLA) ahead of Q2 report
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Jun 30
-
Cantor Fitzgerald Reiterates Overweight Rating on Harrow Health (HROW)
-
Cantor Fitzgerald Reiterates Overweight Rating on Elevance (ELV)
-
Cantor Fitzgerald on Booz Allen Hamilton (BAH): ' Move to Top GovTech Pick'
-
Cantor Fitzgerald on Kratos Defense & Security (KTOS): 'we think this time market sentiment is under-appreciating the upside and sustainability '
-
Form 424B3 Cantor Fitzgerald Income
-
Crypto firm Bitcoin Standard to go public in deal with Cantor-backed SPAC
-
BSTR to go public via SPAC merger with up to $1.5 billion financing
-
Bitcoin Standard Treasury Company to go Public Through Business Combination with Cantor Equity Partners I, Inc.
-
VERAXA Biotech and Voyager file F-4 registration for merger
-
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
-
Cantor Fitzgerald Reiterates Overweight Rating on Iridium Communications (IRDM)
-
Cantor Fitzgerald Reiterates Overweight Rating on ProQR Therapeutics N.V. (PRQR)
-
Cantor Fitzgerald Reiterates Overweight Rating on Rigetti Computing Inc. (RGTI)
-
Cantor Fitzgerald Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)

